Methylphenidate in Treating Patients With Melanoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Methylphenidate may relieve some of the side effects of chemotherapy in patients
with melanoma. It is not known whether receiving methylphenidate is more effective than
receiving no further therapy in treating patients with melanoma.
PURPOSE: Randomized phase III trial to determine if methylphenidate is more effective than no
further therapy for the relief of fatigue and drowsiness in treating patients with melanoma
who have received high-dose interferon alfa for 8-24 weeks.